93 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
51 | 8064320 | Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography. | 1994 May | 1 |
52 | 7907455 | Mechanism of action of cholinesterase inhibitors in Alzheimer's disease. | 1993 | 1 |
53 | 8248533 | Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease. | 1993 | 1 |
54 | 1601960 | Determination of heptylphysostigmine in plasma by high-performance liquid chromatography with electrochemical detection. | 1992 Jan 17 | 1 |
55 | 1791534 | Intranasal absorption of physostigmine and arecoline. | 1991 Aug | 1 |
56 | 1904998 | A model for carbamate and organophosphate-induced emesis in humans. | 1991 Spring | 1 |
57 | 1967018 | Adrenergic-cholinergic imbalances: the physostigmine-syndrome is not antagonized by the MAO-A inhibitor brofaromine. | 1990 Nov | 1 |
58 | 2497488 | Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys. | 1989 | 1 |
59 | 2570433 | Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine. | 1989 | 1 |
60 | 2683549 | Central anticholinergic syndrome (CAS) in anesthesia and intensive care. | 1989 | 1 |
61 | 3069749 | Cortisol responses to cholinergic drugs in Alzheimer's disease. | 1988 Oct | 3 |
62 | 3074841 | Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex. | 1988 | 1 |
63 | 3150807 | Physostigmine enhances blood flow-metabolism ratio in neocortex. | 1988 Dec | 1 |
64 | 2821940 | Pharmacologic evaluation and structure activity relationships of a series of hemicholinium-3 (HC-3) analogs. | 1987 Jul | 1 |
65 | 3435078 | Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. | 1987 Dec | 2 |
66 | 3601008 | A comparison of the effects of two inhibitors on brain cholinesterase. | 1987 Jun | 2 |
67 | 3524957 | Clinical pharmacokinetics of cholinesterase inhibitors. | 1986 May-Jun | 1 |
68 | 3797688 | Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease. | 1986 | 1 |
69 | 3809224 | Perioral behaviors induced by cholinesterase inhibitors: a controversial animal model. | 1986 Dec | 1 |
70 | 2580948 | Substance P in human plasma is degraded by dipeptidyl peptidase IV, not by cholinesterase. | 1985 May | 1 |
71 | 3980055 | Central cardiovascular effects of physostigmine in humans. | 1985 Jan-Feb | 1 |
72 | 3999598 | [Ocular myasthenia]. | 1985 Mar | 1 |
73 | 6143326 | Cholinergic modulation of stimulant-induced behavior. | 1984 Mar | 1 |
74 | 6470148 | Central cholinergic stimulation causes adrenal epinephrine release. | 1984 Sep | 1 |
75 | 6487203 | A cholinomimetic model of motion sickness and space adaptation syndrome. | 1984 Aug | 2 |
76 | 6511307 | A new simple method for determining the kinetic constants of inhibited acetylcholinesterase. | 1984 Sep-Oct | 1 |
77 | 6516793 | Perivascular cholinesterase and morphological blood-brain barrier function. | 1984 Dec | 1 |
78 | 6747844 | Presynaptic inhibitory effect of Met-enkephalin on [14C] acetylcholine release from the myenteric plexus and its interaction with muscarinic negative feedback inhibition. | 1984 Aug | 1 |
79 | 6347034 | Oral physostigmine and lecithin improve memory in Alzheimer disease. | 1983 May | 1 |
80 | 6840979 | Acute administration of individual optimal dose of physostigmine fails to improve mnesic performances in Alzheimers Presenile Dementia. | 1983 | 1 |
81 | 6752738 | A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's disease. | 1982 Summer | 1 |
82 | 7135153 | Alteration of ethanol-induced sleep latency by physostigmine in animals. | 1982 | 1 |
83 | 7217205 | Electron microscope localization of acetylcholinesterase and butyrylcholinesterase in the superior cervical ganglion of the cat. II. Preganglionically denervated ganglion. | 1981 Mar | 1 |
84 | 7298772 | Quantitative determination of the cholinesterase inhibitor physostigmine in brain tissue samples using reversed-phase high-performance liquid chromatography. | 1981 Oct 9 | 1 |
85 | 7188667 | Physostigmine-atropine solution fails to reverse diazepam sedation. | 1980 Jan | 1 |
86 | 445230 | The effects of periarterial nerve activation on coronary vessel tone in an isolated and perfused slab of beef ventricle. | 1979 Mar | 1 |
87 | 30564 | Physostigmine for cardiac and neurologic manifestations of phenothiazine poisoning. | 1978 Dec | 1 |
88 | 203742 | [Diagnosis and treatment of ocular myasthenia (author's transl)]. | 1977 Dec | 1 |
89 | 4343315 | Cholinergic and non-cholinergic transmission in the medial geniculate nucleus of the cat. | 1972 Oct | 1 |
90 | 5315359 | Distribution of cholinesterases in insects. | 1971 | 1 |
91 | 13525672 | The effect of enzyme inhibitors on the resting potential and on the ion distribution of the sartorius muscle of the frog. | 1958 May 20 | 1 |
92 | 19873399 | THE MECHANISM OF ENZYME-INHIBITOR-SUBSTRATE REACTIONS : ILLUSTRATED BY THE CHOLINESTERASE-PHYSOSTIGMINE-ACETYLCHOLINE SYSTEM. | 1944 Jul 20 | 5 |
93 | 19873367 | ZONE BEHAVIOR OF ENZYMES : ILLUSTRATED BY THE EFFECT OF DISSOCIATION CONSTANT AND DILUTION ON THE SYSTEM CHOLINESTERASE-PHYSOSTIGMINE. | 1943 Jul 20 | 1 |